FDA
-
-
-
-
-
-
-
Edesa Biotech Reports Fiscal 1st Quarter 2025 Results
-
-
-
-
-
-
-
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
-
-
-
-
-
-
-
Edesa Biotech (EDSA) Granted FDA Fast Track Designation to its ARDS Drug Candidate
-
-
-
-
-
-
-
Edesa Biotech Receives Canadian Approval to Test COVID-19 Drug as Rescue Therapy
-
-
-
-
-
-
-
Edesa Biotech (EDSA) Reports FDA Approval to Begin COVID-19 Study in the U.S.
-
-
-
-
-
-
-
Edesa Biotech (EDSA) Announces Positive Healthy Volunteer Data & Expands Phase 2b Dermatitis Study to Patients with Facial Lesions
-
-
-
-
-
-
-
Edesa Biotech Completes Manufacturing for Upcoming Dermatitis Study
-
334,127 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


